BackFortress Biotech Overview

Fortress Biotech Long Term Debt

Track Fortress Biotech's long-term debt ($49M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$48.91M
30.34% YoYΔ $-21.30M vs prior year quarter

Peer average

Loading

Fortress Biotech Long Term Debt History

Loading

Fortress Biotech vs. peers: Long Term Debt Comparison

Loading

Fortress Biotech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Fortress Biotech (FBIO) FAQ

As of the most recent data (March 2026), FBIO shows a long-term debt of $49M. That compares with $70M in the prior-year period — down 30.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FBIO's long-term debt is now $49M (was $70M) — a 30.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Fortress Biotech is outperforming or lagging.

Tracking FBIO's long-term debt over time shows whether Fortress Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $49M That compares with $70M in the prior-year period — down 30.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Fortress Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $49M) with ownership activity and broader fundamentals.

Fortress Biotech's long-term debt is $49M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.